UCB, betting on seizure cell therapy, to buy Neurona for up to $1.2B
HealthcareAdd-on
UCB→Neurona Therapeutics
Apr 17, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tracking 1 M&A deal by UCB.
UCB→Neurona Therapeutics
Apr 17, 2026